Amphastar Pharmaceuticals Highlights Baqsimi Milestones, Primatene Growth at Needham Conference [Yahoo! Finance]
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: Yahoo! Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) executives outlined growth drivers, competitive pressures, and pipeline priorities during a fireside chat at Needham & Company's 25th Annual Healthcare Conference. The discussion featured CFO Bill Peters, Senior VP of Corporate Communications Dan Dischner, and Executive VP of Clinical and Regulatory Tony Marrs, moderated by Needham Senior Analyst Serge Belanger. 2025 performance and 2026 outlook Management described Amphastar as a “diversified, branded, and complex generic development and manufacturing company” built on a vertically integrated model. Executives said 2025 showed the strategy working, citing continued scaling of branded products Baqsimi and Primatene Mist, durability in the hospital and injectable portfolio, and contributions from recent launches. ? 3 Surprising S&P 500 Outperformers of 2026 Promising Small Biotech Amphastar Sees Actionable Pullback Peters said the fourth quarter benefited from strong demand for Baqsimi
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Amphastar Pharmaceuticals (AMPH) was downgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "hold (c-)" to "sell (d+)".MarketBeat
- Amphastar Pharmaceuticals (AMPH) had its price target lowered by Barclays PLC from $30.00 to $23.00. They now have an "equal weight" rating on the stock.MarketBeat
- Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- Amphastar Pharmaceuticals: Why I Like Bull Put Options Strategy Here [Seeking Alpha]Seeking Alpha
- Generic Pharmaceuticals Stocks Q4 Highlights: Amphastar Pharmaceuticals (NASDAQ:AMPH) [Yahoo! Finance]Yahoo! Finance
AMPH
Earnings
- 2/26/26 - Miss
AMPH
Sec Filings
- 4/13/26 - Form ARS
- 4/13/26 - Form DEFA14A
- 4/13/26 - Form DEF
- AMPH's page on the SEC website